Literature DB >> 9765058

Characterization of glial filament-cytoskeletal interactions in human astrocytomas: an immuno-ultrastructural analysis.

J T Rutka1, C Ackerley, S L Hubbard, A Tilup, P B Dirks, S Jung, S Ivanchuk, M Kurimoto, A Tsugu, L E Becker.   

Abstract

The role that glial filaments play in cells and tumors of glial origin is not well understood. We therefore undertook the present study to determine the relationships between glial and vimentin intermediate filaments (IFs), actin microfilaments, and CD44, a cell surface glycoprotein important in cell migration and invasion, in human astrocytoma cells. Three astrocytoma cell lines, U343 MG-A (U343), U251 MG (U251), and antisense GFAP-transfected U251 (asU251) were studied using immunofluorescence confocal and immunoelectron microscopy. Furthermore, we studied the phenotypic behaviour of these astrocytoma cell lines by analyzing their migration through Matrigel in vitro. U343 astrocytoma cells had the highest expression levels of glial fibrillary acidic protein (GFAP), whereas asU251 had virtually no expression of GFAP. Parental U251 cells had intermediate expression levels of GFAP. The elimination of GFAP expression in as U251 cells was accompanied by a marked increase in vimentin, actin microfilaments and CD44 levels. Gold labeling density counts of cytoskeletal and cell surface elements demonstrated that the differences between GFAP, actin, CD44 and vimentin levels in the different astrocytoma cell lines were statistically significant (p < 0.05). Results from the in vitro invasion assay revealed that U343 cells demonstrated the least invasive potential, whereas asU251 astrocytoma cells demonstrated the most. Our results show that elimination of GFAP expression by antisense leads to marked alterations in cell morphology and phenotypic behaviour. These data imply that GFAP may be linked spatially and functionally to cytoskeletal elements which may be altered when this IF is deleted in astrocytomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765058     DOI: 10.1016/S0171-9335(98)80006-X

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Assessing the cytoskeletal system and its elements in C6 glioma cells and astrocytes by atomic force microscopy.

Authors:  Dexiang Zhou; Xiaodan Jiang; Ruxiang Xu; Yingqian Cai; Jiliang Hu; Gang Xu; Yuxi Zou; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-03-04       Impact factor: 5.046

3.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 4.  GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas.

Authors:  Jessy V van Asperen; Pierre A J T Robe; Elly M Hol
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

5.  p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.

Authors:  Sreejith P Panicker; Baisakhi Raychaudhuri; Pankaj Sharma; Russell Tipps; Tapati Mazumdar; Asoke K Mal; Juan M Palomo; Michael A Vogelbaum; Saikh Jaharul Haque
Journal:  Oncotarget       Date:  2010-08

6.  Morphological characterization of a human glioma cell l ine.

Authors:  Camila Ml Machado; André Schenka; José Vassallo; Wirla Msc Tamashiro; Estela M Gonçalves; Selma C Genari; Liana Verinaud
Journal:  Cancer Cell Int       Date:  2005-05-10       Impact factor: 5.722

7.  GFAP isoforms control intermediate filament network dynamics, cell morphology, and focal adhesions.

Authors:  Martina Moeton; Oscar M J A Stassen; Jacqueline A Sluijs; Vincent W N van der Meer; Liselot J Kluivers; Hedde van Hoorn; Thomas Schmidt; Eric A J Reits; Miriam E van Strien; Elly M Hol
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.